OAS3 and breast carcinoma: To experimentally validate this hypothesis, bisulfite sequencing analysis was conducted to assess the promoter methylation levels of OAS1, OAS2, OAS3, and OASL in breast cancer cell lines (n = 14) and normal control cell lines (n = 5).